Experience with Lipofilling in Children with Localized Scleroderma: Case Study

Experience with Lipofilling in Children with Localized Scleroderma: Case Study

Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues. The LS prevalence is 27 cases per 1 million per year, and 3.4 cases...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alina R. Misbakhova, Nataliya E. Manturova, Larisa S. Kruglova, Nikolay N. Murashkin, Sofiya R. Mayransaeva
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2024-11-01
Series:	Вопросы современной педиатрии
Subjects:	localized scleroderma focal scleroderma linear scleroderma lipofilling clinical case
Online Access:	https://vsp.spr-journal.ru/jour/article/view/3606
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Face Lesions in En Coup De Sabre Scleroderma in Children: Modern Treatment and Outcomes Improvement
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Extracutaneous Lesions in Patients with Focal Scleroderma of Craniofacial Localization: a Retrospective Cross-Sectional Study
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Morphea profunda – a case report of deep localized scleroderma with severe thorax deformity
by: Natalia Tekiela, et al.
Published: (2025-01-01)

Symptoms of Oesophageal Affection in Children With Scleroderma According to Mano-Impedancemetry: A Case Series
by: Marina Ju. Stepanyan, et al.
Published: (2019-02-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

Clinical and Epidemiological Characteristics of Scleroderma in Children of the Samara Region: a Single-Stage Retrospective Study
by: Juliya S. Bogomolova, et al.
Published: (2025-05-01)

Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center
by: Bugra Han Egeli, et al.
Published: (2025-06-01)

Frequency of occurrenceof tumor-associated localized scleroderma
by: P. O. Kazakova
Published: (2025-05-01)

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01)

Linear Scleroderma and Neurological Complications
by: J Gordon Millichap
Published: (2006-01-01)

Late Diagnosis of Systemic Scleroderma with Vascular Events: Clinical Case
by: Julia S. Bogomolova, et al.
Published: (2024-12-01)

EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01)

Single Sitting Bilateral Dacryocystorhinostomy for Chronic Dacryocystitis in A Patient with Scleroderma and Bipolar Disorder
by: Tara Shruthi, et al.
Published: (2021-04-01)

TUMOR-ASSOCIATED LOCALIZED SCLERODERMA IN CONJUNCTION WITH ACQIRED DISSIMINATED FORM OF VITILIGO: A CLINICAL CASE
by: A. S. Dvornikov, et al.
Published: (2017-03-01)

Autoimmunity and Lymphoma: Splenic Marginal Zone Lymphoma with Scleroderma and Chronic Hepatitis C Virus infection.
by: Ricardo García-Muñoz
Published: (2014-08-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

The indicators of general clinical methods as prognostic markers of the severity of systemic scleroderma complicated by the development of pneumosclerosis.
by: O. V. Karaseva, et al.
Published: (2018-04-01)

Neutrophil-to-lymphocyte ratio: association with microcirculatory changes detected by nailfold capillaroscopy in scleroderma patients and its relation to disease severity
by: Rasha M. Hammoda, et al.
Published: (2025-01-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

THE CASE OF THE DEBUT OF SYSTEMIC SCLERODERMA IN A PATIENT AGED 10
by: А. V. BURLUTSKAYA, et al.
Published: (2018-07-01)

Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
by: E. N. Harlamova, et al.
Published: (2021-01-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

Scleroderma Renal Crisis as Initial Presentation of Scleroderma
by: Sahil Bagai, et al.
Published: (2022-04-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

Upcoming treatments for morphea
by: Dan Wenzel, et al.
Published: (2021-12-01)

Drug-induced fibrosing syndromes: A scoping review
by: Sakir Ahmed, et al.
Published: (2019-01-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

Etiopathogenetic Similarities of Combined Forms of Localized Scleroderma and Vitiligo
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Treatment of parry-romberg syndrome and linear scleroderma en coup de sabre, with application of poly-L-lactic acid (PLLA): assessment of clinical response and high-resolution ultrasonography
by: Renato Roberto Liberato Rostey, et al.
Published: (2025-04-01)

Castleman’s Disease. Association with System Scleroderma
by: A. V. Yagoda, et al.
Published: (2023-10-01)

Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis
by: Ajanee Mahakkanukrauh, et al.
Published: (2025-12-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

Clinical case of morphea associated with a malignant process with extensive skin lesions, which debuted against the background of taking anti-gouty remedy
by: P. O. Kazakova
Published: (2024-11-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

Challenges in diagnosis and treatment of scleroderma renal crisis (clinical case report)
by: E. M. Mishina, et al.
Published: (2025-06-01)

Juvenile Localized Scleroderma. Questions of Treatment
by: Rinat K. Raupov, et al.
Published: (2020-08-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

Neurological and psychological aspects of scleroderma of the face and neck in children
by: M. S. Pavlova, et al.
Published: (2021-06-01)